FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
Titel:
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
Auteur:
Brodowicz, T. Ciuleanu, T.E. Radosavljevic, D. Shacham-Shmueli, E. Vrbanec, D. Plate, S. Mrsic-Krmpotic, Z. Dank, M. Purkalne, G. Messinger, D. Zielinski, C.C.